| 注册
首页|期刊导航|结核与肺部疾病杂志|青蒿素研发的成功经验对结核病防治的借鉴与启示

青蒿素研发的成功经验对结核病防治的借鉴与启示

曹玉清 尚希钰 熊一白 纪鑫毓 马艳

结核与肺部疾病杂志2023,Vol.4Issue(6):442-448,7.
结核与肺部疾病杂志2023,Vol.4Issue(6):442-448,7.DOI:10.19983/j.issn.2096-8493.20230089

青蒿素研发的成功经验对结核病防治的借鉴与启示

Revelation and reference from successful experience of artemisinin to tuberculosis prevention and control

曹玉清 1尚希钰 1熊一白 1纪鑫毓 1马艳1

作者信息

  • 1. 中国中医科学院中医临床基础医学基础所,北京 100700
  • 折叠

摘要

Abstract

The discovery of artemisinin-based antimalarial drugs is a milestone in the history of global antimalarial drug development.It is a major accomplishment achieved by the multi-departmental and multidisciplinary cooperation and mutual cooperation under the organization of scientific research programs,and is a successful example of inheriting and carrying forward the treasure house of traditional medicine in China.Learning the measures of successful experience in artemisinin research and development and drawing experience is important for improving the status quo of tuberculosis preventive treatment,promoting and improving the current tuberculosis prevention and control measures in China,and will play a beneficial role in promoting the goal of ending tuberculosis epidemic as scheduled.

关键词

青蒿素类/结核,肺/思考

Key words

Artemisinins/Tuberculosis,pulmonary/Thinking

分类

医药卫生

引用本文复制引用

曹玉清,尚希钰,熊一白,纪鑫毓,马艳..青蒿素研发的成功经验对结核病防治的借鉴与启示[J].结核与肺部疾病杂志,2023,4(6):442-448,7.

基金项目

National Natural Science Foundation of China(82274350) (82274350)

Scientific and Technological Innovation Project of CACMS(CI2021A00704,CI2021A01314,CI2021B003)国家自然科学基金(82274350) (CI2021A00704,CI2021A01314,CI2021B003)

中国中医科学院科技创新工程项目(CI2021A00704,CI2021A01314,CI2021B003) (CI2021A00704,CI2021A01314,CI2021B003)

结核与肺部疾病杂志

2096-8493

访问量0
|
下载量0
段落导航相关论文